Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
In a filing, Regulus Therapeutics Inc revealed its Chief Executive Officer Hagan Joseph P unloaded Company’s shares for reported $17359.0
Regulus Therapeutics Inc’s recent filing unveils that its Chief Executive Officer Hagan Joseph P unloaded Company’s shares for reported $17359.0
Regulus Therapeutics Inc. (RGLS) shares gained 15.69% to $1.92 in Monday’s early session after reporting positive clinical trial results. A